In addition, miR-30b-5p inhibits lung cancer cell viability, migration and invasion and enhances cell sensitivity to cysplatin via targeting LRP8, suggesting that miR-30b-5p inhibits lung cancer progression by targeting LRP8 [147]. This evidence concerns the gene LRP8 and lung cancer.